APA

Shukla S., Chufan E. E., Singh S., Skoumbourdis A. P., Kapoor K., Boxer M. B., Duveau D. Y., Thomas C. J., Talele T. T. & Ambudkar S. V. (20140616). Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein. : Leukemia.

Chicago

Shukla S, Chufan E E, Singh S, Skoumbourdis A P, Kapoor K, Boxer M B, Duveau D Y, Thomas C J, Talele T T and Ambudkar S V. 20140616. Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein. : Leukemia.

Harvard

Shukla S., Chufan E. E., Singh S., Skoumbourdis A. P., Kapoor K., Boxer M. B., Duveau D. Y., Thomas C. J., Talele T. T. and Ambudkar S. V. (20140616). Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein. : Leukemia.

MLA

Shukla S, Chufan E E, Singh S, Skoumbourdis A P, Kapoor K, Boxer M B, Duveau D Y, Thomas C J, Talele T T and Ambudkar S V. Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein. : Leukemia. 20140616.